Loading chat...

IL HB4623

Bill

Status

Introduced

2/5/2020

Primary Sponsor

Bob Morgan

Click for details

Origin

House of Representatives

101st General Assembly

AI Summary

  • Employers may adopt drug testing policies for registered medical cannabis qualifying patients, but may only enforce these policies for employees in "safety sensitive positions" as defined in the bill.

  • Employers cannot take adverse action against registered qualifying patients in non-safety sensitive positions solely due to a positive cannabis drug test, unless the result exceeds limits in Illinois Vehicle Code Section 11-501.2, the patient failed to provide required written notice, or the patient failed to certify their status as a registered qualifying patient.

  • "Safety sensitive positions" include roles involving firearms, medical procedures, child or patient care, financial responsibilities of $5,000 or more, hazardous materials, sensitive personal information, food handling, or positions where inattention could cause injury or damage.

  • Employers may consider a registered qualifying patient impaired only if cannabis levels exceed the Illinois Vehicle Code limits or if the patient manifests specific articulable symptoms of impairment while working that decrease job performance.

  • Amendments to the Right to Privacy in the Workplace Act clarify that provisions of the Compassionate Use of Medical Cannabis Program Act are exceptions to protections for lawful off-premises product use by employees.

Legislative Description

COMPASSIONATE USE-LIABILITY

Last Action

Rule 19(b) / Re-referred to Rules Committee

6/23/2020

Committee Referrals

Rules6/23/2020
Labor & Commerce2/18/2020
Rules2/5/2020

Full Bill Text

No bill text available